BLOSSOMHILL THERAPEUTICS, INC.

Consensus BlossomHill Therapeutics, Inc.

Stocks

BLSM

US0951301003

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 13/11/2026 GMT			5-day change	1st Jan Change
14.02 ^USD	-5.53%		+3.85%	-

11-12	BlossomHill Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
11-09	BlossomHill Therapeutics to Advance BH-30643 to Phase 2 After FDA Alignment on Dosage	MT

Evolution of the Average Target: BlossomHill Therapeutics, Inc.

Evolution of the Average Target - BlossomHill Therapeutics, Inc.

Evolution of the Target Price: BlossomHill Therapeutics, Inc.

Evolution of the Target Price - BlossomHill Therapeutics, Inc.

Changes in Analyst Recommendations: BlossomHill Therapeutics, Inc.

a7469a59ee7895.LacnZdjwLtfhb3fgb7Cq2gYtamiLn8D9WGjRDjLuWxE.QO9jMq3GXYSbXDqqHIjomFFsLgLR-7iiKiC8OkWiNUlf-G0dlZQa4I1WLg~efece09d4c67f416dfbcd34b520a7d48

Analysts' recommendations: BlossomHill Therapeutics, Inc.

09-01	Leerink Partners Initiates BlossomHill Therapeutics at Outperform, $36 Price Target	MT
09-01	JPMorgan Initiates BlossomHill Therapeutics at Overweight	MT
09-01	Guggenheim Initiates BlossomHill Therapeutics at Buy With $30 Price Target	MT
09-01	HC Wainwright Initiates BlossomHill Therapeutics at Buy With $35 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BLOSSOMHILL THERAPEUTICS, INC.					+152.5%
	WUXI APPTEC CO., LTD.					+38.3%
	ARGENX SE					+15.44%
	LONZA GROUP AG					+7.53%
	BEONE MEDICINES AG					+12.65%
	IQVIA HOLDINGS INC.					+17.64%
	REVOLUTION MEDICINES, INC.					+59.52%
	CELLTRION, INC.					+30.16%
	GENMAB A/S					+17.66%
	INSMED INCORPORATED					+60.27%
	Average					+41.17%
	Weighted average by Cap.					+26.62%

See all sector performances

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

14.02USD

Average target price

35.40USD

Spread / Average Target

+152.50%

High Price Target

40.00USD

Spread / Highest target

+185.31%

Low Price Target

30.00USD

Spread / Lowest Target

+113.98%

Analyst Consensus Detail

Analyst consensus - BlossomHill Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - BlossomHill Therapeutics, Inc.

Stock Market
Stocks
BLSM Stock
Consensus BlossomHill Therapeutics, Inc.